|
| Home : Financing Increases Runway to the Clinic for COTI-2, Critical Outcome's Lead Cancer Drug Candidate |
|
May 01
2014 |
Financing Increases Runway to the Clinic for COTI-2, Critical Outcome's Lead Cancer Drug Candidate |
|
LONDON, ONTARIO--(Marketwired - May 1, 2014) - Critical Outcome Technologies Inc. (TSX VENTURE:COT) ("COTI" or the "Corporation") the bioinformatics and accelerated drug discovery company, is pleased to announce the completion of a non-brokered private placement of 3,356,250 units (the "Units") at a price of $0.16 per Unit for gross proceeds of $537,000. |
|
|
|
| Source:http://www.marketwired.com/mw/release.do?id=1905257&sourceType=3 |
| |
|
Related News
|
» Teranga Announces Closing of $29,880,000 Offering
» Gold Royalties Corporation: Closing of Financing and Corporate Update
|
|
|
